Companies
/
Inari
Healthtech
Inari is a Cambridge, Massachusetts-based agricultural biotechnology company using gene editing and predictive design technology to develop improved crop seed varieties more efficiently than traditional breeding methods.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Inari was founded in 2016 by a team including Ponsi Trivisvavet, drawing on advances in gene editing technology, computational biology, and machine learning, based on the observation that traditional crop breeding, even when assisted by modern genomic tools, remains a largely trial-and-error process involving breeding many different plant variations and observing which ones happen to perform best across many growing seasons, a process that, while it has produced significant crop improvements over decades, is inherently slow and doesn't fully take advantage of the increasingly detailed scientific understanding of plant genetics and the specific genetic changes that drive desirable traits like drought tolerance, yield, or disease resistance. Inari's approach, which it describes as "seed design," combines computational modeling and machine learning to predict which specific genetic changes are likely to produce desired crop traits, then uses precise gene editing technology to make those specific, targeted genetic changes directly, rather than relying primarily on the more traditional, slower process of crossing different plant varieties and observing outcomes across many growing seasons to gradually breed toward desired traits. The company has argued this predictive design approach can develop improved crop varieties, such as seeds requiring less water, fertilizer, or land to produce a given amount of food, significantly faster than traditional breeding timelines allow, an important consideration given mounting pressure on global agriculture to produce more food using fewer natural resources amid climate change and population growth pressures. Inari has focused its seed design technology on major row crops including corn, soybeans, and wheat, crops that represent an enormous share of global agricultural land use and food production, arguing that even modest efficiency improvements applied at this global scale could have cumulative environmental and food security benefits. The company has raised very substantial venture funding from investors including Flagship Pioneering, Warburg Pincus, and Bill Gates' investment vehicles, reaching unicorn status, positioning itself within the broader agricultural biotechnology and gene editing category alongside other companies pursuing similar precision agriculture technology.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
No news available for this company.
